Kenvue Inc.
KVUEKenvue Inc. (KVUE) is a consumer health company that focuses on the development, manufacturing, and marketing of well-known health, wellness, and personal care brands. It was established as a separate entity following the spin-off from Johnson & Johnson and aims to leverage its portfolio of trusted brands in skincare, oral care, pain relief, and other consumer health segments.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| May 27, 2026 | $0.21 | 2026-05-13 | 2026-05-13 |
| February 25, 2026 | $0.21 | 2026-02-11 | 2026-02-11 |
| November 26, 2025 | $0.21 | 2025-11-12 | 2025-11-12 |
| August 27, 2025 | $0.21 | 2025-08-13 | 2025-08-13 |
| May 28, 2025 | $0.20 | 2025-05-14 | 2025-05-14 |
Dividends Summary
- Consistent Payer: Kenvue Inc. has rewarded shareholders with 12 dividend payments over the past 3 years.
- Total Returned Value: Investors who held KVUE shares during this period received a total of $2.45 per share in dividend income.
- Latest Payout: The most recent dividend of $0.21/share was paid 52 days ago, on May 27, 2026.
- Yield & Schedule: KVUE currently pays dividends quarterly with an annual yield of 4.37%.
- Dividend Growth: Since 2023, the dividend payout has grown by 3.7%, from $0.20 to $0.21.
- Dividend Reliability: KVUE has maintained or increased its dividend for 12 consecutive payments.
Company News
Ken Griffin increased his stake in Johnson & Johnson by 146% in Q1 2026, bringing his total holdings to nearly 2 million shares. The article highlights J&J as an ideal stock for risk-averse investors due to its diversified portfolio of 28+ billion-dollar products, strong revenue growth in pharmaceuticals and medtech following the Kenvue spinoff, ...
The article compares Church & Dwight and Kimberly-Clark as investment options in the consumer goods sector. Church & Dwight operates a lean portfolio of power brands with a strong balance sheet (0.6x debt-to-equity), while Kimberly-Clark is a larger global player undergoing transformation with higher leverage (4.9x debt-to-equity). The author rec...
Kimberly-Clark is outperforming the S&P 500 and Nasdaq in 2026 with a 4.5% dividend yield and 54 consecutive years of dividend increases. The company trades at a discount valuation (15.2x 2026 earnings vs. 21.9x historical median) and is acquiring Kenvue to diversify revenue streams and unlock $2.1 billion in annual synergies. However, risks incl...
Colgate-Palmolive has surged 20.4% year-to-date and stands out as a Dividend King with 63 consecutive years of dividend increases. Despite industry headwinds from inflation and consumer resistance to price increases, the company has demonstrated resilience through its elite brand portfolio, efficient operations, and strong geographic diversificat...
The article recommends three healthcare stocks for long-term buy-and-hold portfolios: Johnson & Johnson, Abbott Laboratories, and UnitedHealth Group. All three are praised for their stable dividends, strong cash flows, economic moats, and ability to weather economic downturns. Johnson & Johnson and Abbott are Dividend Kings with 64 and 54 consecu...
